Replies to post #8542 on Titan Pharmaceuticals Inc (TTNP)

[TRUISM]

An article stated Braeburn was seriously considering it.

“We are definitely interested in talking to the FDA about the use of Probuphine in pain,” said Behshad Sheldon, President and CEO of Braeburn.

Click For Article




Blessings to All

TRUTH

[Doctor Detroit]

I think so...I thought all buprenorphine was Schedule III.